Chemed Future Growth

Future criteria checks 0/6

Chemed's earnings are forecast to decline at 18.9% per annum while its annual revenue is expected to grow at 6.5% per year. EPS is expected to decline by 19.1% per annum.

Key information

-18.9%

Earnings growth rate

-19.1%

EPS growth rate

Healthcare earnings growth	16.0%
Revenue growth rate	6.5%
Future return on equity	n/a
Analyst coverage	Low
Last updated	25 Apr 2024

Recent future growth updates

Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

Mar 01

Recent updates

Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Apr 26

Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

Mar 01

Chemed: Still Bullish On Economic Characteristics, But Risks Shouldn't Be Overlooked

Aug 13

Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?

Aug 01

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Jul 14

Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet

Jun 07

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Apr 09

Chemed Q4 2022 Earnings Preview

Feb 22

Chemed Corporation: Long-Term Tailwinds, But Remains A Hold

Feb 14

Is Chemed (NYSE:CHE) Using Too Much Debt?

Jan 05

Here's What Chemed's (NYSE:CHE) Strong Returns On Capital Mean

Dec 17

Chemed declares $0.38 dividend

Nov 04

Chemed Q3 2022 Earnings Preview

Oct 28

Does Chemed (NYSE:CHE) Have A Healthy Balance Sheet?

Oct 01

Capital Investment Trends At Chemed (NYSE:CHE) Look Strong

Sep 16

Buy Chemed To Reduce Equity Beta And Stabilize Portfolio Returns

Aug 26

A Look At The Intrinsic Value Of Chemed Corporation (NYSE:CHE)

Aug 16

Chemed declares $0.38 dividend

Aug 05

Chemed Q2 results mixed, co increases top end of FY 2022 adj. EPS guidance range

Jul 27

Is Chemed (NYSE:CHE) A Risky Investment?

Jun 29

Chemed announces a five-year $550M amended and restated senior secured credit facility

Jun 29

Returns on Capital Paint A Bright Future For Chemed (NYSE:CHE)

Jun 14

Estimating The Intrinsic Value Of Chemed Corporation (NYSE:CHE)

May 14

Is Chemed (NYSE:CHE) Using Too Much Debt?

Mar 25

Earnings and Revenue Growth Forecasts

NYSE:CHE - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	2,743	N/A	509	509	2
12/31/2025	2,595	356	411	472	4
12/31/2024	2,433	319	376	435	4
3/31/2024	2,293	283	302	354	N/A
12/31/2023	2,264	273	273	330	N/A
9/30/2023	2,225	245	259	322	N/A
6/30/2023	2,187	226	280	345	N/A
3/31/2023	2,165	240	208	269	N/A
12/31/2022	2,135	250	253	310	N/A
9/30/2022	2,129	262	220	273	N/A
6/30/2022	2,141	277	284	334	N/A
3/31/2022	2,142	267	249	303	N/A
12/31/2021	2,139	269	250	309	N/A
9/30/2021	2,132	308	271	332	N/A
6/30/2021	2,121	303	283	344	N/A
3/31/2021	2,091	329	450	507	N/A
12/31/2020	2,080	319	430	489	N/A
9/30/2020	2,069	271	410	466	N/A
6/30/2020	2,021	263	413	470	N/A
3/31/2020	1,992	231	258	317	N/A
12/31/2019	1,939	220	248	301	N/A
9/30/2019	1,874	209	238	294	N/A
6/30/2019	1,837	201	218	275	N/A
3/31/2019	1,806	205	241	296	N/A
12/31/2018	1,783	206	234	287	N/A
9/30/2018	1,753	206	152	202	N/A
6/30/2018	1,727	190	123	183	N/A
3/31/2018	1,700	113	91	159	N/A
12/31/2017	1,667	98	N/A	162	N/A
9/30/2017	1,642	76	N/A	198	N/A
6/30/2017	1,617	67	N/A	162	N/A
3/31/2017	1,592	114	N/A	197	N/A
12/31/2016	1,577	109	N/A	135	N/A
9/30/2016	1,572	106	N/A	187	N/A
6/30/2016	1,566	108	N/A	175	N/A
3/31/2016	1,557	111	N/A	166	N/A
12/31/2015	1,543	110	N/A	172	N/A
9/30/2015	1,524	110	N/A	172	N/A
6/30/2015	1,496	106	N/A	135	N/A
3/31/2015	1,475	103	N/A	134	N/A
12/31/2014	1,456	99	N/A	110	N/A
9/30/2014	1,425	92	N/A	66	N/A
6/30/2014	1,408	85	N/A	111	N/A
3/31/2014	1,405	76	N/A	131	N/A
12/31/2013	1,413	77	N/A	151	N/A
9/30/2013	1,433	81	N/A	190	N/A
6/30/2013	1,447	84	N/A	162	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CHE's earnings are forecast to decline over the next 3 years (-18.9% per year).

Earnings vs Market: CHE's earnings are forecast to decline over the next 3 years (-18.9% per year).

High Growth Earnings: CHE's earnings are forecast to decline over the next 3 years.

Revenue vs Market: CHE's revenue (6.5% per year) is forecast to grow slower than the US market (8.2% per year).

High Growth Revenue: CHE's revenue (6.5% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if CHE's Return on Equity is forecast to be high in 3 years time

Discover growth companies

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Chemed Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Chemed Corporation Reiterates Earnings Guidance for Full Year 2024

Price target increased by 10% to US$690

Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

Chemed Corporation Provides Earnings Guidance for the Full-Year 2023

Chemed Corporation Provides Earnings Guidance for the Year 2022

Chemed Corporation Provides Earnings Guidance for the Year 2022

Recent updates

Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Chemed Corporation Reiterates Earnings Guidance for Full Year 2024

First quarter 2024 earnings: EPS misses analyst expectations

Chemed Corporation, Annual General Meeting, May 20, 2024

New major risk - Revenue and earnings growth

Executive Vice President exercised options and sold US$3.8m worth of stock

Executive Vice President recently sold US$1.3m worth of stock

Chemed Corporation to Report Q1, 2024 Results on Apr 24, 2024

Price target increased by 10% to US$690

Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Now 22% overvalued after recent price rise

Third quarter dividend of US$0.40 announced

Chemed Corporation Declares Quarterly Dividend, Payable on March 15, 2024

Chemed Corporation to Report Q4, 2023 Results on Feb 27, 2024

The Price Is Right For Chemed Corporation (NYSE:CHE)

Chemed Corporation Appoints Michael D. Witzeman as Chief Financial Officer, Effective January 1, 2024

CEO, President & Director recently sold US$859k worth of stock

Chemed: Continues To Compound Shareholder Value At Double-Digit Returns

Executive Vice President recently sold US$580k worth of stock

Executive VP & CFO notifies of intention to sell stock

Chemed Corporation Announces the Retirement of David P. Williams as Chief Financial Officer Effective December 31, 2023

Chemed Corporation Announces the Retirement of David P. Williams as Chief Financial Officer Effective December 31, 2023

Executive VP & CFO exercised options to buy US$5.9m worth of stock.

CEO, President & Director recently sold US$1.7m worth of stock

Chemed Corporation Provides Earnings Guidance for the Full-Year 2023

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Chemed Corporation to Report Q3, 2023 Results on Oct 25, 2023

Chemed - Showcasing Why It's So Reliable

Chemed: Still Bullish On Economic Characteristics, But Risks Shouldn't Be Overlooked

CEO, President & Director recently sold US$2.1m worth of stock

Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Chemed Corporation to Report Q2, 2023 Results on Jul 26, 2023

Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet

Executive Vice President notifies of intention to sell stock

Independent Director recently sold US$160k worth of stock

Independent Director notifies of intention to sell stock

CEO, President & Director recently sold US$2.2m worth of stock

CEO, President & Director exercised options and sold US$412k worth of stock

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

CEO, President & Director recently sold US$1.6m worth of stock

Executive VP & CFO recently sold US$2.1m worth of stock

CEO, President & Director recently sold US$1.0m worth of stock

CEO, President & Director exercised options to buy US$1.2m worth of stock.

Full year 2022 earnings: EPS misses analyst expectations

Chemed Q4 2022 Earnings Preview

Chemed Corporation Declares Quarterly Cash Dividend Payable on March 17, 2023

Chemed Corporation: Long-Term Tailwinds, But Remains A Hold

Chemed Corporation to Report Q4, 2022 Results on Feb 23, 2023

Is Chemed (NYSE:CHE) Using Too Much Debt?

Here's What Chemed's (NYSE:CHE) Strong Returns On Capital Mean

VP & Director exercised options and sold US$226k worth of stock

CEO, President & Director recently sold US$1.0m worth of stock

Executive VP & CFO exercised options and sold US$2.3m worth of stock

Executive VP & CFO recently sold US$4.0m worth of stock

CEO, President & Director recently sold US$966k worth of stock

Chemed Corporation Declares Quarterly Cash Dividend on the Capital Stock, Payable on December 5, 2022

Chemed declares $0.38 dividend

Third quarter 2022 earnings: EPS misses analyst expectations

Chemed Corporation Provides Earnings Guidance for the Year 2022

Chemed Q3 2022 Earnings Preview

Chemed Corporation to Report Q3, 2022 Results on Oct 31, 2022

Does Chemed (NYSE:CHE) Have A Healthy Balance Sheet?

Capital Investment Trends At Chemed (NYSE:CHE) Look Strong

CEO, President & Director recently sold US$948k worth of stock